David J. King

3.1k total citations
72 papers, 2.4k citations indexed

About

David J. King is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, David J. King has authored 72 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Radiology, Nuclear Medicine and Imaging, 28 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in David J. King's work include Monoclonal and Polyclonal Antibodies Research (35 papers), Glycosylation and Glycoproteins Research (14 papers) and Protein purification and stability (7 papers). David J. King is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (35 papers), Glycosylation and Glycoproteins Research (14 papers) and Protein purification and stability (7 papers). David J. King collaborates with scholars based in United Kingdom, United States and China. David J. King's co-authors include G. T. Yarranton, Donald I. Abrams, C. R. Bebbington, Scott Thomson, G. Renner, Stephen Cooper, John R. Adair, Mark Bodmer, Sarojani Angal and Peter M. Bowers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

David J. King

69 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. King United Kingdom 28 1.3k 1.2k 374 356 170 72 2.4k
Michael M. Schmidt United States 14 789 0.6× 809 0.6× 542 1.4× 202 0.6× 37 0.2× 26 2.0k
Michael A. Bowen United States 29 594 0.5× 1.1k 0.9× 592 1.6× 1.2k 3.3× 34 0.2× 91 2.9k
Zhiyu Chen China 21 411 0.3× 871 0.7× 432 1.2× 342 1.0× 62 0.4× 119 2.2k
Motomu Shimaoka United States 40 856 0.7× 1.6k 1.3× 290 0.8× 1.8k 5.0× 120 0.7× 92 5.1k
Harald Kropshofer Germany 34 960 0.7× 1.4k 1.1× 508 1.4× 2.4k 6.6× 57 0.3× 73 4.5k
Tsutomu Okada Japan 26 760 0.6× 317 0.3× 127 0.3× 638 1.8× 139 0.8× 71 2.2k
David Naor Israel 29 372 0.3× 2.0k 1.6× 846 2.3× 1.3k 3.7× 52 0.3× 136 4.3k
Stephen M. Mahler Australia 28 675 0.5× 1.4k 1.1× 275 0.7× 724 2.0× 16 0.1× 93 3.2k
Richard Luong United States 30 259 0.2× 823 0.7× 704 1.9× 820 2.3× 39 0.2× 61 3.5k
George Alexandrakis United States 26 692 0.5× 355 0.3× 194 0.5× 56 0.2× 74 0.4× 83 1.9k

Countries citing papers authored by David J. King

Since Specialization
Citations

This map shows the geographic impact of David J. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. King more than expected).

Fields of papers citing papers by David J. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. King. The network helps show where David J. King may publish in the future.

Co-authorship network of co-authors of David J. King

This figure shows the co-authorship network connecting the top 25 collaborators of David J. King. A scholar is included among the top collaborators of David J. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. King. David J. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adams, Ryan A., Cátia Fernandes‐Cerqueira, Antonella Notarnicola, et al.. (2019). Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses. Cellular and Molecular Immunology. 18(6). 1463–1475. 26 indexed citations
2.
King, David J., Peter M. Bowers, Marilyn R. Kehry, & Robert A. Horlick. (2014). Mammalian Cell Display and Somatic Hypermutation In Vitro for Human Antibody Discovery. Current Drug Discovery Technologies. 11(1). 56–64. 23 indexed citations
3.
Bowers, Peter M., Petra Verdino, Zhengyuan Wang, et al.. (2014). Nucleotide Insertions and Deletions Complement Point Mutations to Massively Expand the Diversity Created by Somatic Hypermutation of Antibodies. Journal of Biological Chemistry. 289(48). 33557–33567. 14 indexed citations
4.
Zhang, Xue, John L. Macomber, Betty Chau, et al.. (2014). A general approach to antibody thermostabilization. mAbs. 6(5). 1274–1282. 44 indexed citations
5.
Bowers, Peter M., Tamlyn Y. Neben, Xue Zhang, et al.. (2013). Humanization of Antibodies Using Heavy Chain Complementarity-determining Region 3 Grafting Coupled with in Vitro Somatic Hypermutation. Journal of Biological Chemistry. 288(11). 7688–7696. 16 indexed citations
6.
Horlick, Robert A., John L. Macomber, Peter M. Bowers, et al.. (2013). Simultaneous Surface Display and Secretion of Proteins from Mammalian Cells Facilitate Efficient in Vitro Selection and Maturation of Antibodies. Journal of Biological Chemistry. 288(27). 19861–19869. 27 indexed citations
7.
Macomber, John L., Athena Chen, Robert A. Horlick, et al.. (2012). An integrated approach to extreme thermostabilization and affinity maturation of an antibody. Protein Engineering Design and Selection. 26(2). 151–164. 48 indexed citations
8.
Bowers, Peter M., Robert A. Horlick, Tamlyn Y. Neben, et al.. (2011). Coupling mammalian cell surface display with somatic hypermutation for the discovery and maturation of human antibodies. Proceedings of the National Academy of Sciences. 108(51). 20455–20460. 78 indexed citations
9.
Pan, Chin, Jonathan Terrett, Chetana Rao, et al.. (2008). Human antibody conjugates of potential utility for prostate cancer therapy: A comparison of MGBA conjugates with antibodies targeting a cell surface target (prostate-specific membrane antigen) and an extracellular matrix target (Mindin/RG-1). Cancer Research. 68. 4062–4062. 1 indexed citations
10.
Clarke, Mary, et al.. (2003). Eye movements and neurocognitive function in treatment resistant schizophrenia: a pilot study. Irish Journal of Psychological Medicine. 20(1). 6–10. 3 indexed citations
11.
Casey, Joanne L., Mark Napier, David J. King, et al.. (2002). Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study. British Journal of Cancer. 86(9). 1401–1410. 35 indexed citations
12.
Clark, Kevin D., Brian F. Volkman, Honglada Thoetkiattikul, et al.. (2001). Alanine-scanning Mutagenesis of Plasmatocyte Spreading Peptide Identifies Critical Residues for Biological Activity. Journal of Biological Chemistry. 276(21). 18491–18496. 25 indexed citations
13.
Lund, John, Noriko Takahashi, Andrew G. Popplewell, et al.. (2000). Expression and characterization of truncated forms of humanized L243 IgG1. European Journal of Biochemistry. 267(24). 7246–7257. 29 indexed citations
14.
Carrasco, Beatriz, José Garcı́a de la Torre, Olwyn Byron, et al.. (1999). Novel Size-Independent Modeling of the Dilute Solution Conformation of the Immunoglobulin IgG Fab′ Domain Using SOLPRO and ELLIPS. Biophysical Journal. 77(6). 2902–2910. 25 indexed citations
15.
King, David J.. (1998). An algorithm for detecting heavy-truck driver fatigue from steering wheel motion. 2. 873–882. 14 indexed citations
16.
Angal, Sarojani, David J. King, Mark Bodmer, et al.. (1993). A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Molecular Immunology. 30(1). 105–108. 187 indexed citations
17.
King, David J., et al.. (1992). The Effect of Neuroleptics on Cognitive and Psychomotor Function. The British Journal of Psychiatry. 160(5). 647–653. 25 indexed citations
18.
Bebbington, C. R., G. Renner, Scott Thomson, et al.. (1992). High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker. Nature Biotechnology. 10(2). 169–175. 351 indexed citations
19.
Siegel, Marshall M., Irwin Hollander, Philip R. Hamann, et al.. (1991). Matrix-assisted UV-laser desorption/ionization mass spectrometric analysis of monoclonal antibodies for the determination of carbohydrate, conjugated chelator, and conjugated drug content. Analytical Chemistry. 63(21). 2470–2481. 65 indexed citations
20.
King, David J. & Stephen Cooper. (1989). Viruses, Immunity and Mental Disorder. The British Journal of Psychiatry. 154(1). 1–7. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael M. Schmidt Breakdown of academic impact, for papers by Michael A. Bowen Breakdown of academic impact, for papers by Zhiyu Chen Breakdown of academic impact, for papers by Motomu Shimaoka Breakdown of academic impact, for papers by Harald Kropshofer Breakdown of academic impact, for papers by Tsutomu Okada Breakdown of academic impact, for papers by David Naor Breakdown of academic impact, for papers by Stephen M. Mahler Breakdown of academic impact, for papers by Richard Luong Breakdown of academic impact, for papers by George Alexandrakis
Rankless by CCL
2026